Pharmaceutical Technology Europe
The author reviews Warning Letters issued between 2000 and mid-2010 for aseptic processing and non-sterile processing, and determines how many observations were made for each section of the GMPs.
Jeanne Moldenhauer
Advertisement
Jeanne Moldenhauer is Vice President of Excellent Pharma Consulting, Inc. 404 Washington Blvd, Mundelein, IL 60060 (USA). [email protected]
Tel. +1 847 837 8191
Articles by Jeanne Moldenhauer
Pharmaceutical Technology Europe
A review of warning letters from the last 10 years relating specifically to cleanrooms has indicated several concerns with the appropriateness of cleanroom design - primarily regarding air flow and laminarity.
Advertisement
Latest Updated Articles
- Review of FDA Warning Letters
April 1st 2011
- Passing Cleanroom Inspections
November 30th 2010
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
PharmTech Weekly Roundup—June 19, 2026
5